A breakthrough pancreatic cancer drug won approval. They still struggle to access it
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for quick access have been stymied.
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for quick access have been stymied.
comments(0)
5-min edit window · permanent after that